The association of micronucleus frequency with obesity, diabetes and cardiovascular disease

Mutagenesis

Volumn 26, Issue 1, 2011, Pages 77-83

  Andreassi, Maria Grazia ^a   Barale, Roberto ^b   Iozzo, Patricia ^a   Picano, Eugenio ^a  

^a INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

^b UNIVERSITY OF PISA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOVASCULAR DISEASE; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE SEVERITY; HUMAN; IMPAIRED GLUCOSE TOLERANCE; MICRONUCLEUS; MORTALITY; OBESITY; OVARY POLYCYSTIC DISEASE; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; REVIEW;

CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; MALE; METABOLIC SYNDROME X; MICRONUCLEI, CHROMOSOME-DEFECTIVE; MICRONUCLEUS TESTS; OBESITY; PROGNOSIS;

EID: 78650656433     PISSN: 02678357     EISSN: 14643804     Source Type: Journal    
DOI: 10.1093/mutage/geq077     Document Type: Review

References (59)

1. American Heart association (2003) Heart Disease and Stroke Statistics-2004 Update. American Heart Association, Dallas, TX, USA.
2. Murray, C. J. and Lopez, A. D. (1997) Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet., 349, 1498-1504.
3. Alberti, K. G., Eckel, R. H., Grundy, S. M., Zimmet, P. Z., Cleeman, J. I., Donato, K. A., Fruchart, J. C., Loria, C. M. and Smith, S. C. (2009) Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation, 120, 1640-1645.
4. Executive summary of the Third Report of The National Cholesterol Education Program (NCEP-ATP III) (2001) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA, 285, 2486-2497.
5. Grundy, S. M. (2008) Metabolic syndrome pandemic. Arterioscler. Thromb. Vasc. Biol., 28, 629-636.
6. Amos, A., McCarty, D. and Zimmet, P. (1997) The rising global burden of diabetes and its complications: estimates and projections to the year 2010. Diabet. Med., 14, S1-S85.
7. Vigneri, P., Frasca, F., Sciacca, L., Pandini, G. and Vigneri, R. (2009) Diabetes and cancer. Endocr. Relat. Cancer, 16, 1103-1123.
8. Andreassi, M. G. (2008) DNA damage, vascular senescence, and atherosclerosis. J. Mol. Med., 86, 1033-1043.
9. Fenech, M. and Morley, A. A. (1985) Measurement of micronuclei in lymphocytes. Mutat. Res., 147, 29-36.
10. Fenech, M. (2007) Cytokinesis-block micronucleus cytome assay. Nat. Protoc., 2, 1084-1104.
11. Ogden, C. L., Carroll, M. D., Curtin, L. R., McDowell, M. A., Tabak, C. J. and Flegal, K. M. (2006) Prevalence of overweight and obesity in the United States, 1999-2004. JAMA, 295, 1549-1555.
12. Ode, K. L., Frohnert, B. I. and Nathan, B. M. (2009) Identification and treatment of metabolic complications in pediatric obesity. Rev. Endocr. Metab. Disord., 10, 167-188.
13. Vincent, H. K., Innes, K. E. and Vincent, K. R. (2007) Oxidative stress and potential interventions to reduce oxidative stress in overweight and obesity. Diabetes Obes. Metab., 9, 813-839.
14. Iozzo, P. (2009) Viewpoints on the way to the consensus session: where does insulin resistance start? The adipose tissue. Diabetes Care, 32, S168-S173.
15. Vassalle, C., Pratali, L., Boni, C., Mercuri, A. and Ndreu, R. (2008) Age-related oxidative stress modulation by smoking habit and obesity. Clin. Biochem., 41, 1162-1167.
16. Bukhari, S. A., Rajoka, M. I., Nagra, S. A. and Rehman, Z. U. (2010) Plasma homocysteine and DNA damage profiles in normal and obese subjects in the Pakistani population. Mol. Biol. Rep., 37, 289-295.
17. Demirbag, R., Yilmaz, R., Gur, M., Celik, H., Guzel, S., Selek, S. and Kocyigit, A. (2006) DNA damage in metabolic syndrome and its association with antioxidative and oxidative measurements. Int. J. Clin. Pract., 60, 1187-1193.
18. Moran, L. J., Noakes, M., Clifton, P. M., Norman, R. J. and Fenech, M. F. (2008) Genome instability is increased in lymphocytes of women with polycystic ovary syndrome and is correlated with insulin resistance. Mutat. Res., 639, 55-63.
19. Yesilada, E., Sahin, I., Ozcan, H., Yildirim, I. H., Yologlu, S. and Taskapan, C. (2006) Increased micronucleus frequencies in peripheral blood lymphocytes in women with polycystic ovary syndrome. Eur. J. Endocrinol., 154, 563-568.
20. Hamurcu, Z., Bayram, F., Kahriman, G., Dönmez-Altuntas, H. and Baskol, G. (2010) Micronucleus. frequency in lymphocytes and 8-hydroxydeoxyguanosine level in plasma of women with polycystic ovary syndrome. Gynecol. Endocrinol., 26, 590-595.
21. Goodarz, M. O. and Azziz, R. (2006) Diagnosis, epidemiology, and genetics of the polycystic ovary syndrome. Best Pract. Res. Clin. Endocrinol. Metab., 20, 193-205. (Pubitemid 43842923)
22. Dandona, P., Thusu, K., Cook, S., Snyder, B., Makowski, J., Armstrong, D. and Nicotera, T. (1996) Oxidative damage to DNA in diabetes mellitus. Lancet, 347, 444-445.
23. Hinokio, Y., Suzuki, S., Hirai, M., Chiba, M., Hirai, A. and Toyota, T. (1999) Oxidative DNA damage in diabetes mellitus: its association with diabetic complications. Diabetologia, 42, 995-998. (Pubitemid 29369608)
24. Collins, A. R., Raslova, K., Somorovska, M., Petrovská, H., Ondrusová, A., Vohnout, B., Fábry, R. and Dusinská, M. (1998) DNA damage in diabetes: correlation with a clinical marker. Free Radic. Biol. Med., 25, 373-377.
25. Botto, N., Masetti, S., Petrozzi, L., Vassalle, C., Manfredi, S., Biagini, A. and Andreassi, M. G. (2002) Elevated levels of oxidative DNA damage in patients with coronary artery disease. Coron. Artery Dis., 13, 269-274.
26. Shin, C. S., Moon, B. S., Park, K. S., Kim, S. Y., Park, S. J., Chung, M. H. and Lee, H. K. (2001) Serum 8-hydroxy-guanine levels are increased in diabetic patients. Diabetes Care, 24, 733-737.
27. Andreassi, M. G., Botto, N., Simi, S., Casella, M., Manfredi, S., Lucarelli, M., Venneri, L., Biagini, A. and Picano, E. (2005) Diabetes and chronic nitrate therapy as co-determinants of somatic DNA damage in patients with coronary artery disease. J. Mol. Med., 83, 279-286.
28. Sheth, F. J., Patel, P., Vaidya, A. D. B., Vaidya, R. and Sheth, J. (2006) Increased frequency of sister chromatid exchanges in patients with type II diabetes. Curr. Sci., 90, 236-240.
29. Boehm, B. O., Möller, P., Högel, J. et al. (2008) Lymphocytes of type 2 diabetic women carry a high load of stable chromosomal aberrations: a novel risk factor for disease-related early death. Diabetes, 57, 2950-2957.
30. Cinkilic, N., Kiyici, S., Celikler, S., Vatan, O., Oz Gul, O., Tuncel, E. and Bilaloglu, R. (2009) Evaluation of chromosome aberrations, sister chromatid exchange and micronuclei in patients with type-1 diabetes mellitus. Mutat. Res., 676, 1-4.
31. Mart́inez-Pérez, L. M., Cerda-Flores, R. M., Gallegos-Cabriales, E. C., Dávila-Rodŕiguez, M. I., Ibarra-Costilla, E. and Cortés-Gutiérrez, E. I. (2007) Frequency of micronuclei in Mexicans with type 2 diabetes mellitus. Prague Med. Rep., 108, 248-255.
32. Zúñiga-González, G. M., Batista-González, C. M., Gómez-Meda, B. C., Ramos-Ibarra, M. L., Zamora-Perez, A. L., Muñoz-Magallanes, T., Ramos-Valdés, C. and Gallegos-Arreola, M. P. (2007) Micronuclei in diabetes: folate supplementation diminishes micronuclei in diabetic patients but not in an animal model. Mutat. Res., 634, 126-134.
33. Ross, R. (1999) Atherosclerosis-an inflammatory disease. N. Engl. J. Med., 340, 115-126.
34. Andreassi, M. G. (2003) Coronary atherosclerosis and somatic mutations: an overview of the contributive factors for oxidative DNA damage. Mutat. Res., 543, 67-86.
35. Mercer, J., Mahmoudi, M. and Bennett, M. (2007) DNA damage, p53, apoptosis and vascular disease. Mutat. Res., 621, 75-86.
36. De Flora, S. and Izzotti, A. (2007) Mutagenesis and cardiovascular diseases Molecular mechanisms, risk factors, and protective factors. Mutat. Res., 621, 5-17.
37. Casalone, R., Granata, P., Minelli, E., Portentoso, P., Giudici, A., Righi, R., Castelli, P., Socrate, A. and Frigerio, B. (1991) Cytogenetic analysis reveals clonal proliferation of smooth muscle cells in atherosclerotic plaques. Hum. Genet., 87, 139-143.
38. Tokunaga, O., Satoh, T. and Yu, S. (2002) Multinucleated variant endothelial cells (MVECs) have a greater capacity for LDL cholesterol uptake than typical mononuclear endothelial cells (TECs). J. Atheroscler. Thromb., 9, 35-41.
39. Matturri, L., Cazzullo, A., Turconi, P., Lavezzi, A. M., Vandone, P. L., Gabrielli, L., Fernandez Alonso, G., Grana, D. and Milei, J. (2001) Chromosomal alterations in atherosclerotic plaques. Atherosclerosis, 154, 755-761.
40. Hatzistamou, J., Kiaris, H., Ergazaki, M. and Spandidos, D. A. (1996) Loss of heterozygosity and microsatellite instability in human atherosclerotic plaques. Biochem. Biophys. Res. Commun., 225, 186-190. (Pubitemid 26285417)
41. Flouris, G. A., Arvanitis, D. A., Parissis, J. T., Arvanitis, D. L. and Spandidos, D. A. (2000) Loss of heterozygosity in DNA mismatch repair genes in human atherosclerotic plaques. Mol. Cell Biol. Res. Commun., 4, 62-65.
42. Grati, F. R., Ghilardi, G., Sirchia, S. M., Massaro, F., Cassani, B., Scorza, R., De Andreis, C., Sironi, E. and Simoni, G. (2001) Loss of heterozygosity of the NOS3 dinucleotide repeat marker in atherosclerotic plaques of human carotid arteries. Atherosclerosis, 159, 261-267.
43. Arvanitis, D. A., Flouris, G. A. and Spandidos, D. A. (2005) Genomic rearrangements on VCAM1, SELE, APEG1and AIF1 loci in atherosclerosis. J. Cell. Mol. Med., 9, 153-159.
44. De Flora, S., Izzotti, A., Walsh, D., Degan, P., Petrilli, G. L. and Lewtas, J. (1997) Molecular epidemiology of atherosclerosis. FASEB J., 11, 1021-1031.
45. Van Schooten, F. J., Hirvonen, A., Maas, L. M., De Mol, B. A., Kleinjans, J. C., Bell, D. A. and Durrer, J. D. (1998) Putative susceptibility markers of coronary artery disease: association between VDR genotype, smoking, and aromatic DNA adduct levels in human right atrial tissue. FASEB J., 12, 1409-1417.
46. Martinet, W., Knaapen, M. W., De Meyer, G. R., Herman, A. G. and Kockx, M. M. (2002) Elevated levels of oxidative DNA damage and DNA repair enzymes in human atherosclerotic plaques. Circulation, 106, 927-932.
47. Demirbag, R., Yilmaz, R., Gur, M., Kocyigit, A., Celik, H., Guzel, S. and Selek, S. (2005) Lymphocyte DNA damage in patients with acute coronary syndrome and its relationship with severity of acute coronary syndrome. Mutat. Res., 578, 298-307.
48. Botto, N., Rizza, A., Colombo, M. G., Mazzone, A. M., Manfredi, S., Masetti, S., Clerico, A., Biagini, A. and Andreassi, M. G. (2001) Evidence for DNA damage in patients with coronary artery disease. Mutat. Res., 493, 23-30.
49. Guven, M., Guven, G. S., Oz, E., Ozaydin, A., Batar, B., Ulutin, T., Hacihanefioglu, S. and Domanic, N. (2007) DNA repair gene XRCC1 and XPD polymorphisms and their association with coronary artery disease risks and micronucleus frequency. Heart Vessels, 22, 355-360.
50. Andreassi, M. G., Botto, N., Rizza, A. et al. (2002) Deoxyribonucleic acid damage in human lymphocytes after percutaneous transluminal coronary angioplasty. J. Am. Coll. Cardiol., 40, 862-868.
51. Andreassi, M. G., Cioppa, A., Manfredi, S., Palmieri, C., Botto, N. and Picano, E. (2007) Acute chromosomal DNA damage in human lymphocytes after radiation exposure in invasive cardiovascular procedures. Eur. Heart J., 28, 2195-2199.
52. Thomas, P. and Fenech, M. (2008) Methylenetetrahydrofolate reductase, common polymorphisms, and relation to disease. Vitam. Horm., 79, 375-392.
53. Andreassi, M. G., Botto, N., Cocci, F. et al. (2003) Methylenetetrahy- drofolate reductase gene C677T polymorphism, homocysteine, vitamin B12 and DNA damage in coronary artery disease. Hum. Genet., 112, 171-177.
54. Murgia, E., Maggini, V., Barale, R. and Rossi, A. M. (2007) Micronuclei, genetic polymorphisms and cardiovascular disease mortality in a nested case-control study in Italy. Mutat. Res., 612, 113-118.
55. Federici, C., Botto, N., Manfredi, S., Rizza, A., Del Fiandra, M. and Andreassi, M. G. (2008) Relation of increased chromosomal damage to future adverse cardiac events in patients with known coronary artery disease. Am. J. Cardiol., 102, 1296-1300.
56. Pavanello, S., Pesatori, A. C., Dioni, L. et al. (2010) Shorter telomere length in peripheral blood lymphocytes of workers exposed to polycyclic aromatic hydrocarbons. Carcinogenesis, 31, 216-221.
57. Huang, P., Huang, B., Weng, H., Nakayama, K. and Morimoto, K. (2009) Effects of lifestyle on micronuclei frequency in human lymphocytes in Japanese hard-metal workers. Prev. Med., 48, 383-388.
58. Ozanne, S. E. and Hales, C. N. (2002) Early programming of glucose-insulin metabolism. Trends Endocrinol. Metab., 13, 368-373.
59. Boney, C. M., Verma, A., Tucker, R. and Vohr, B. R. (2005) Metabolic syndrome in childhood: association with birth weight, maternal obesity, and gestational diabetes mellitus. Pediatrics, 115, e290-e296.